Browsing Tag
Bone Biologics
2 posts
Bone Biologics files new U.S. patent for NELL-1-based bone regeneration in spinal fusion
Bone Biologics files U.S. patent for rhNELL-1 bone regeneration in spine fusion, expanding IP ahead of clinical development. Learn what it means for investors.
Bone Biologics prices $5m equity and warrant offering to accelerate spinal fusion trial development
Bone Biologics Corporation has priced a $5 million public offering to advance its spine fusion therapy trials and intellectual property. Learn what this means for investors.